DK3744316T3 - Oftalmisk farmaceutisk sammensætning, fremgangsmåde til fremstilling deraf og anvendelse deraf - Google Patents
Oftalmisk farmaceutisk sammensætning, fremgangsmåde til fremstilling deraf og anvendelse deraf Download PDFInfo
- Publication number
- DK3744316T3 DK3744316T3 DK19743390.7T DK19743390T DK3744316T3 DK 3744316 T3 DK3744316 T3 DK 3744316T3 DK 19743390 T DK19743390 T DK 19743390T DK 3744316 T3 DK3744316 T3 DK 3744316T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- pharmaceutical composition
- ophthalmic pharmaceutical
- ophthalmic
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810063904.7A CN108785251B (zh) | 2018-01-23 | 2018-01-23 | 一种眼用药物组合物及其制备方法和应用 |
| PCT/CN2019/072664 WO2019144863A1 (zh) | 2018-01-23 | 2019-01-22 | 一种眼用药物组合物及其制备方法和应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3744316T3 true DK3744316T3 (da) | 2023-10-16 |
Family
ID=64094622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19743390.7T DK3744316T3 (da) | 2018-01-23 | 2019-01-22 | Oftalmisk farmaceutisk sammensætning, fremgangsmåde til fremstilling deraf og anvendelse deraf |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20210030833A1 (da) |
| EP (2) | EP4279063A3 (da) |
| JP (2) | JP7418351B2 (da) |
| KR (1) | KR20200113243A (da) |
| CN (2) | CN112516080B (da) |
| AU (1) | AU2019212565A1 (da) |
| BR (1) | BR112020014950A2 (da) |
| CA (1) | CA3089344A1 (da) |
| DK (1) | DK3744316T3 (da) |
| ES (1) | ES2960069T3 (da) |
| FI (1) | FI3744316T3 (da) |
| HR (1) | HRP20231069T1 (da) |
| HU (1) | HUE063566T2 (da) |
| IL (1) | IL276244A (da) |
| LT (1) | LT3744316T (da) |
| PL (1) | PL3744316T3 (da) |
| PT (1) | PT3744316T (da) |
| RS (1) | RS64732B1 (da) |
| SG (1) | SG11202007077YA (da) |
| SI (1) | SI3744316T1 (da) |
| WO (1) | WO2019144863A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112516080B (zh) * | 2018-01-23 | 2023-09-19 | 盛元医药广州有限公司 | 一种眼用药物组合物及其制备方法和应用 |
| CN109771370B (zh) * | 2019-02-28 | 2021-03-30 | 厦门大学 | 一种眼内手术用前房灌注液及其用途 |
| CN113171340B (zh) * | 2021-05-07 | 2022-12-06 | 四川科伦药业股份有限公司 | 一种丙氨酰谷氨酰胺注射液及其生产工艺 |
| WO2023098537A1 (zh) * | 2021-12-01 | 2023-06-08 | 盛元医药广州有限公司 | 丙谷二肽的新用途和包含丙谷二肽的眼用组合物 |
| CN114869873A (zh) * | 2022-05-05 | 2022-08-09 | 陈小鸟 | 谷氨酰胺在制备治疗干眼症的药物中的应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0455596B1 (de) * | 1990-05-04 | 1994-11-02 | Novartis AG | Substituierte Indole |
| EP0539329A1 (de) * | 1991-10-25 | 1993-04-28 | Ciba-Geigy Ag | Acetylen-Verbindungen, verwendbar als Leukotrien-Antagonisten |
| GB9419011D0 (en) * | 1994-09-21 | 1994-11-09 | Peptech Uk Ltd | Use of muramyl peptide compounds |
| WO2002090380A1 (en) * | 2001-04-17 | 2002-11-14 | Sankt-Peterburgskaya Obschestvennaya Organizatsiya 'institut Bioregulyatsii I Gerontologii Czo Ramn' | Tetrapeptide stimulating the retinal function and the method of its application |
| JP2006504701A (ja) | 2002-09-30 | 2006-02-09 | マーク・エー・バビザイェフ | 眼疾患の局所的治療方法、並びに、その治療用組成物及び治療用手段 |
| US20050089547A1 (en) * | 2003-09-26 | 2005-04-28 | Josef Neu | Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation |
| US8629099B2 (en) * | 2008-03-25 | 2014-01-14 | Bausch & Lomb Incorporated | Ophthalmic compositions comprising a dipeptide |
| WO2010107069A1 (ja) * | 2009-03-17 | 2010-09-23 | 千寿製薬株式会社 | アミノ酸含有眼科用組成物 |
| EP2478010B1 (en) * | 2009-09-16 | 2014-08-06 | Senju Pharmaceutical Co., Ltd. | Partial peptide of lacritin |
| TW201225972A (en) | 2010-11-15 | 2012-07-01 | Univ Ramot | Dipeptide analogs for treating conditions associated with amyloid fibril formation |
| US20130225684A1 (en) * | 2012-02-28 | 2013-08-29 | Kyowa Hakko Bio Co., Ltd. | Methods and compositions for enhancement of vision performance |
| RU2498570C1 (ru) * | 2012-05-03 | 2013-11-20 | Государственное бюджетное учреждение "Уфимский научно-исследовательский институт глазных болезней Академии наук Республики Башкортостан" | Раствор для хранения роговицы |
| EP3262060B1 (en) * | 2015-02-25 | 2019-12-25 | MacKay Memorial Hospital | Peptides for use in the prevention and treatment of dry eye |
| CN107049938B (zh) * | 2017-05-11 | 2021-01-05 | 艾迈德(厦门)生物科技有限公司 | 一种用于治疗干眼的滴眼液 |
| CN112516080B (zh) * | 2018-01-23 | 2023-09-19 | 盛元医药广州有限公司 | 一种眼用药物组合物及其制备方法和应用 |
-
2018
- 2018-01-23 CN CN202011477050.0A patent/CN112516080B/zh active Active
- 2018-01-23 CN CN201810063904.7A patent/CN108785251B/zh active Active
-
2019
- 2019-01-22 US US16/964,108 patent/US20210030833A1/en not_active Abandoned
- 2019-01-22 JP JP2020562816A patent/JP7418351B2/ja active Active
- 2019-01-22 ES ES19743390T patent/ES2960069T3/es active Active
- 2019-01-22 SG SG11202007077YA patent/SG11202007077YA/en unknown
- 2019-01-22 WO PCT/CN2019/072664 patent/WO2019144863A1/zh active Application Filing
- 2019-01-22 FI FIEP19743390.7T patent/FI3744316T3/fi active
- 2019-01-22 HR HRP20231069TT patent/HRP20231069T1/hr unknown
- 2019-01-22 BR BR112020014950-0A patent/BR112020014950A2/pt unknown
- 2019-01-22 EP EP23193774.9A patent/EP4279063A3/en active Pending
- 2019-01-22 PL PL19743390.7T patent/PL3744316T3/pl unknown
- 2019-01-22 PT PT197433907T patent/PT3744316T/pt unknown
- 2019-01-22 SI SI201930640T patent/SI3744316T1/sl unknown
- 2019-01-22 HU HUE19743390A patent/HUE063566T2/hu unknown
- 2019-01-22 EP EP19743390.7A patent/EP3744316B1/en active Active
- 2019-01-22 CA CA3089344A patent/CA3089344A1/en active Pending
- 2019-01-22 LT LTEPPCT/CN2019/072664T patent/LT3744316T/lt unknown
- 2019-01-22 RS RS20230803A patent/RS64732B1/sr unknown
- 2019-01-22 AU AU2019212565A patent/AU2019212565A1/en active Pending
- 2019-01-22 KR KR1020207024348A patent/KR20200113243A/ko not_active Application Discontinuation
- 2019-01-22 DK DK19743390.7T patent/DK3744316T3/da active
-
2020
- 2020-07-23 IL IL276244A patent/IL276244A/en unknown
-
2023
- 2023-11-22 US US18/518,134 patent/US20240148818A1/en active Pending
-
2024
- 2024-01-09 JP JP2024001117A patent/JP2024045187A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| SI3744316T1 (sl) | 2024-01-31 |
| JP2024045187A (ja) | 2024-04-02 |
| JP2021512172A (ja) | 2021-05-13 |
| EP3744316A4 (en) | 2021-12-08 |
| CN108785251B (zh) | 2020-11-24 |
| EP4279063A3 (en) | 2024-02-14 |
| US20210030833A1 (en) | 2021-02-04 |
| FI3744316T3 (fi) | 2023-09-12 |
| ES2960069T3 (es) | 2024-02-29 |
| EP3744316B1 (en) | 2023-08-30 |
| IL276244A (en) | 2020-09-30 |
| AU2019212565A1 (en) | 2020-08-13 |
| EP4279063A2 (en) | 2023-11-22 |
| HRP20231069T1 (hr) | 2023-12-22 |
| CN112516080B (zh) | 2023-09-19 |
| RS64732B1 (sr) | 2023-11-30 |
| JP7418351B2 (ja) | 2024-01-19 |
| CN112516080A (zh) | 2021-03-19 |
| HUE063566T2 (hu) | 2024-01-28 |
| RU2020127883A (ru) | 2022-02-24 |
| EP3744316A1 (en) | 2020-12-02 |
| CA3089344A1 (en) | 2019-08-01 |
| KR20200113243A (ko) | 2020-10-06 |
| SG11202007077YA (en) | 2020-08-28 |
| CN108785251A (zh) | 2018-11-13 |
| US20240148818A1 (en) | 2024-05-09 |
| WO2019144863A1 (zh) | 2019-08-01 |
| LT3744316T (lt) | 2023-11-10 |
| PL3744316T3 (pl) | 2024-04-15 |
| BR112020014950A2 (pt) | 2020-12-08 |
| PT3744316T (pt) | 2023-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3453707T3 (da) | Benzazepinderivat, fremgangsmåde til fremstilling, farmaceutisk sammensætning og anvendelse deraf | |
| DK3717471T3 (da) | Nye forbindelser og lægemiddelsammensætninger heraf til behandling af sygdomme | |
| DK3486242T3 (da) | Oxopicolinamidderivat, fremgangsmåde til fremstilling deraf og farmaceutisk anvendelse deraf | |
| DK3744316T3 (da) | Oftalmisk farmaceutisk sammensætning, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| DK3281614T3 (da) | Multifunktionel formulering omfattende naturlige bestanddele og fremgangsmåde til forberedelse/fremstilling deraf | |
| DK4011908T3 (da) | Ultralangtidsvirkende insulin-FC-fusionsproteiner og fremgangsmåder til anvendelse deraf | |
| DK3557998T3 (da) | Sammensætninger, kompositioner og anvendelsesmetoder | |
| DK3381469T3 (da) | Anti-erbb2 antistoflægemiddelskonjugat og sammensætning deraf, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
| DK3565579T3 (da) | Pd1-41bbl-fusionsprotein og fremgangsmåder til anvendelse deraf | |
| DK3618928T3 (da) | Anti-Sortilin-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3388420T3 (da) | Quinolin-forbindelser, metode til fremstilling deraf og anvendelse deraf som urattransporter-hæmmende lægemiddel | |
| DK3380525T3 (da) | Farmaceutiske formuleringer og fremgangsmåder til anvendelse deraf | |
| IL283968A (en) | Benzamides of pyrazole-amino-pyrimidine type substances and their use | |
| DK3404024T3 (da) | Quinazolinonderivat, fremgangsmåde til fremstilling deraf, farmaceutisk sammensætning og anvendelser | |
| DK3574135T3 (da) | Fremgangsmåde og formulering til fremstilling af ligninfibre | |
| DK3937902T3 (da) | Farmaceutisk doseringsform til påføring på slimhinder og fremgangsmåder til fremstilling af denne | |
| DK3398598T3 (da) | Sulfonamidderivat og fremstillingsmetode og anvendelse deraf | |
| DK3512597T3 (da) | Manchetelektrode eller -optrode med bløde kanter og fremgangsmåde til fremstilling heraf | |
| DK3721718T3 (da) | Trelagskapsel bestående af ikke-hydrogeneret fedt, og fremgangsmåde til fremstilling deraf | |
| DK3688147T3 (da) | Hidtil ukendt lægemiddelindgivelsessystem og fremgangsmåder til tilvejebringelse heraf | |
| EP3785713A4 (en) | CETAGLIPTINE SALT, METHOD OF MANUFACTURING IT, PHARMACEUTICAL COMPOSITION AND USE OF IT | |
| IL274123A (en) | Co-crystals, their pharmaceutical preparations and treatment methods involving them | |
| DK3503885T3 (da) | Farmaceutisk præparat og fremgangsmåder til anvendelse heraf | |
| DK3399040T3 (da) | Fremgangsmåde til fremstilling af porcine circovirus type 2 capsid-protein og farmaceutisk sammensætning omfattende samme |